Literature DB >> 33546722

In vivo tau pathology is associated with synaptic loss and altered synaptic function.

Emma M Coomans1,2, Deborah N Schoonhoven3,4, Hayel Tuncel5, Sander C J Verfaillie5, Emma E Wolters5,3, Ronald Boellaard5, Rik Ossenkoppele3,6, Anouk den Braber3, Wiep Scheper3,7,8, Patrick Schober9, Steven P Sweeney10, J Michael Ryan10, Robert C Schuit5, Albert D Windhorst5, Frederik Barkhof5,11, Philip Scheltens3, Sandeep S V Golla5, Arjan Hillebrand4, Alida A Gouw3,4, Bart N M van Berckel5.   

Abstract

BACKGROUND: The mechanism of synaptic loss in Alzheimer's disease is poorly understood and may be associated with tau pathology. In this combined positron emission tomography (PET) and magnetoencephalography (MEG) study, we aimed to investigate spatial associations between regional tau pathology ([18F]flortaucipir PET), synaptic density (synaptic vesicle 2A [11C]UCB-J PET) and synaptic function (MEG) in Alzheimer's disease.
METHODS: Seven amyloid-positive Alzheimer's disease subjects from the Amsterdam Dementia Cohort underwent dynamic 130-min [18F]flortaucipir PET, dynamic 60-min [11C]UCB-J PET with arterial sampling and 2 × 5-min resting-state MEG measurement. [18F]flortaucipir- and [11C]UCB-J-specific binding (binding potential, BPND) and MEG spectral measures (relative delta, theta and alpha power; broadband power; and peak frequency) were assessed in cortical brain regions of interest. Associations between regional [18F]flortaucipir BPND, [11C]UCB-J BPND and MEG spectral measures were assessed using Spearman correlations and generalized estimating equation models.
RESULTS: Across subjects, higher regional [18F]flortaucipir uptake was associated with lower [11C]UCB-J uptake. Within subjects, the association between [11C]UCB-J and [18F]flortaucipir depended on within-subject neocortical tau load; negative associations were observed when neocortical tau load was high, gradually changing into opposite patterns with decreasing neocortical tau burden. Both higher [18F]flortaucipir and lower [11C]UCB-J uptake were associated with altered synaptic function, indicative of slowing of oscillatory activity, most pronounced in the occipital lobe.
CONCLUSIONS: These results indicate that in Alzheimer's disease, tau pathology is closely associated with reduced synaptic density and synaptic dysfunction.

Entities:  

Keywords:  Alzheimer; MEG; PET; Synaptic density; Synaptic function; Tau

Mesh:

Substances:

Year:  2021        PMID: 33546722      PMCID: PMC7866464          DOI: 10.1186/s13195-021-00772-0

Source DB:  PubMed          Journal:  Alzheimers Res Ther            Impact factor:   6.982


  67 in total

Review 1.  Potential of functional MRI as a biomarker in early Alzheimer's disease.

Authors:  Reisa Sperling
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

Review 2.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

3.  Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue.

Authors:  Michel Koole; June van Aalst; Martijn Devrome; Nathalie Mertens; Kim Serdons; Brigitte Lacroix; Joel Mercier; David Sciberras; Paul Maguire; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-18       Impact factor: 9.236

4.  In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.

Authors:  Hanna Cho; Jae Yong Choi; Mi Song Hwang; You Jin Kim; Hye Mi Lee; Hye Sun Lee; Jae Hoon Lee; Young Hoon Ryu; Myung Sik Lee; Chul Hyoung Lyoo
Journal:  Ann Neurol       Date:  2016-07-08       Impact factor: 10.422

5.  MR-based automatic delineation of volumes of interest in human brain PET images using probability maps.

Authors:  Claus Svarer; Karine Madsen; Steen G Hasselbalch; Lars H Pinborg; Steven Haugbøl; Vibe G Frøkjaer; Søren Holm; Olaf B Paulson; Gitte M Knudsen
Journal:  Neuroimage       Date:  2004-12-09       Impact factor: 6.556

6.  Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.

Authors:  Sjoerd J Finnema; Nabeel B Nabulsi; Joël Mercier; Shu-Fei Lin; Ming-Kai Chen; David Matuskey; Jean-Dominique Gallezot; Shannan Henry; Jonas Hannestad; Yiyun Huang; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-09       Impact factor: 6.200

7.  Imaging synaptic density in the living human brain.

Authors:  Sjoerd J Finnema; Nabeel B Nabulsi; Tore Eid; Kamil Detyniecki; Shu-Fei Lin; Ming-Kai Chen; Roni Dhaher; David Matuskey; Evan Baum; Daniel Holden; Dennis D Spencer; Joël Mercier; Jonas Hannestad; Yiyun Huang; Richard E Carson
Journal:  Sci Transl Med       Date:  2016-07-20       Impact factor: 17.956

Review 8.  EEG dynamics in patients with Alzheimer's disease.

Authors:  Jaeseung Jeong
Journal:  Clin Neurophysiol       Date:  2004-07       Impact factor: 3.708

9.  Neuronal activity enhances tau propagation and tau pathology in vivo.

Authors:  Jessica W Wu; S Abid Hussaini; Isle M Bastille; Gustavo A Rodriguez; Ana Mrejeru; Kelly Rilett; David W Sanders; Casey Cook; Hongjun Fu; Rick A C M Boonen; Mathieu Herman; Eden Nahmani; Sheina Emrani; Y Helen Figueroa; Marc I Diamond; Catherine L Clelland; Selina Wray; Karen E Duff
Journal:  Nat Neurosci       Date:  2016-06-20       Impact factor: 24.884

10.  In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.

Authors:  Adam P Mecca; Ming-Kai Chen; Ryan S O'Dell; Mika Naganawa; Takuya Toyonaga; Tyler A Godek; Joanna E Harris; Hugh H Bartlett; Wenzhen Zhao; Nabeel B Nabulsi; Brent C Vander Wyk; Pradeep Varma; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Alzheimers Dement       Date:  2020-05-13       Impact factor: 21.566

View more
  10 in total

1.  1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults.

Authors:  Firat Kara; James M Joers; Dinesh K Deelchand; Young Woo Park; Scott A Przybelski; Timothy G Lesnick; Matthew L Senjem; Burcu Zeydan; David S Knopman; Val J Lowe; Prashanthi Vemuri; Michelle M Mielke; Mary M Machulda; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2022-01-05       Impact factor: 4.673

2.  Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.

Authors:  Adam P Mecca; Ming-Kai Chen; Ryan S O'Dell; Mika Naganawa; Takuya Toyonaga; Tyler A Godek; Joanna E Harris; Hugh H Bartlett; Wenzhen Zhao; Emmie R Banks; Gessica S Ni; Kelly Rogers; Jean Dominique Gallezot; Jim Ropchan; Paul R Emery; Nabeel B Nabulsi; Brent C Vander Wyk; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2021-11-20       Impact factor: 4.673

3.  Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.

Authors:  Yi-He Chen; Rong-Rong Lin; Hui-Feng Huang; Yan-Yan Xue; Qing-Qing Tao
Journal:  Front Aging Neurosci       Date:  2022-06-30       Impact factor: 5.702

4.  The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer's Pathogenesis via Specific Pathways.

Authors:  Hongle Wu; Wei Qiu; Xiaofang Zhu; Xiangfen Li; Zhongcong Xie; Isabel Carreras; Alpaslan Dedeoglu; Thomas Van Dyke; Yiping W Han; Nadeem Karimbux; Qisheng Tu; Lei Cheng; Jake Chen
Journal:  Front Aging Neurosci       Date:  2022-06-23       Impact factor: 5.702

5.  Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11 C]UCB-J.

Authors:  Adam P Mecca; Ryan S O'Dell; Emily S Sharp; Emmie R Banks; Hugh H Bartlett; Wenzhen Zhao; Sylwia Lipior; Nina G Diepenbrock; Ming-Kai Chen; Mika Naganawa; Takuya Toyonaga; Nabeel B Nabulsi; Brent C Vander Wyk; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Alzheimers Dement       Date:  2022-02-17       Impact factor: 16.655

6.  Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.

Authors:  Negin Holland; Maura Malpetti; Timothy Rittman; Elijah E Mak; Luca Passamonti; Sanne S Kaalund; Frank H Hezemans; P Simon Jones; George Savulich; Young T Hong; Tim D Fryer; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  Brain       Date:  2022-03-29       Impact factor: 15.255

Review 7.  Positron Emission Tomography in Animal Models of Tauopathies.

Authors:  Lei Cao; Yanyan Kong; Bin Ji; Yutong Ren; Yihui Guan; Ruiqing Ni
Journal:  Front Aging Neurosci       Date:  2022-01-10       Impact factor: 5.750

8.  Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.

Authors:  Alex I Wiesman; Daniel L Murman; Rebecca A Losh; Mikki Schantell; Nicholas J Christopher-Hayes; Hallie J Johnson; Madelyn P Willett; Sara L Wolfson; Kathryn L Losh; Craig M Johnson; Pamela E May; Tony W Wilson
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

9.  A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease.

Authors:  Niels D Prins; John E Harrison; Hui-May Chu; Kelly Blackburn; John J Alam; Philip Scheltens
Journal:  Alzheimers Res Ther       Date:  2021-05-27       Impact factor: 6.982

10.  Synaptic density in carriers of C9orf72 mutations: a [11 C]UCB-J PET study.

Authors:  Maura Malpetti; Negin Holland; P Simon Jones; Rong Ye; Thomas E Cope; Tim D Fryer; Young T Hong; George Savulich; Timothy Rittman; Luca Passamonti; Elijah Mak; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  Ann Clin Transl Neurol       Date:  2021-06-16       Impact factor: 5.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.